Exploring Alternative In Vitro Models for Final Formulation Testing of OTC Antic
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is seeking to explore and validate alternative in vitro models for the final formulation testing of over-the-counter anticaries drug products. Current regulations under the OTC Monograph M021 require animal caries reduction tests for fluoride toothpastes, but scientific advancements have introduced animal-free methods such as pH cycling. These alternatives evaluate the mineral content of tooth enamel using various techniques, including micro-computed tomography, spectroscopy, microscopy, and microhardness. This proposed study focuses on examining and comparing several evaluation techniques to address the need for standardization, particularly regarding microhardness evaluation. By refining these experimental parameters, the project aims to develop valid, standardized alternatives to animal testing for regulatory use. This multifaceted approach will ultimately help modernize the testing requirements for toothpastes marketed under the M021 monograph.
General Info
Place of Performance
USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
